Market revenue in 2024 | USD 190.8 million |
Market revenue in 2030 | USD 265.8 million |
Growth rate | 5.7% (CAGR from 2025 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.6% in 2024. Horizon Databook has segmented the Middle East & Africa dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
Countries in the Middle East & Africa (MEA) such as South Africa, Saudi Arabia, and the UAE are prospering economies. The market in this region is driven by high prevalence of dry eye disease, rise in consumer awareness, and improvements in healthcare infrastructure. Thus, MEA is a largely untapped market for dry eye treatment drugs, with the presence of lucrative opportunities for players.
Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are some of the primary factors driving the growth of this market. There is high prevalence of dry eye disease in this region. However, ethical reasons, poor infrastructure, and affordability may hamper the market growth in this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa dry eye syndrome treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account